DLL3 and small cell lung carcinoma: In the wake of such promising data, Liu et al. developed a CAR-NK system in which delta-like ligand 3 (DLL3), which is a cell surface protein overexpressed in 70% of SCLC cases, was exploited to induce tumour-specific regression in this cell subtype [100].